Heterologous Omicron-adapted vaccine as a secondary booster promotes neutralizing antibodies against Omicron and its sub-lineages in mice

Over one billion people have received 2–3 dosages of an inactivated COVID-19 vaccine for basic immunization. Whether a booster dose should be delivered to protect against the Omicron variant and its sub-lineages, remains controversial. Here, we tested different vaccine platforms targeting the ancest...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jianyang, He, Qian, Gao, Fan, Bian, Lianlian, Wang, Qian, An, Chaoqiang, Song, Lifang, Zhang, Jialu, Liu, Dong, Song, Ziyang, Li, Lu, Bai, Yu, Wang, Zhongfang, Liang, Zhenglun, Mao, Qunying, Xu, Miao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Coronaviruses
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9754032/
https://www.ncbi.nlm.nih.gov/pubmed/36377297
http://dx.doi.org/10.1080/22221751.2022.2143283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9754032/
https://www.ncbi.nlm.nih.gov/pubmed/36377297
http://dx.doi.org/10.1080/22221751.2022.2143283

Ejemplares similares